Cancer drugs speed to accelerated approvals, then hit the brakes in timely, clinically beneficial confirmatory trials.

IF 2.5 4区医学 Q2 HEALTH CARE SCIENCES & SERVICES

American Journal of Managed Care Pub Date : 2024-08-01 DOI:10.37765/ajmc.2024.89597

Terra Wonsettler

引用次数: 0

查看原文本刊更多论文

抗癌药物加速审批，然后在及时的、对临床有益的确证试验中踩刹车。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Managed Care 医学-卫生保健

CiteScore

3.60

自引率

0.00%

发文量

177

审稿时长

4-8 weeks

期刊介绍： The American Journal of Managed Care is an independent, peer-reviewed publication dedicated to disseminating clinical information to managed care physicians, clinical decision makers, and other healthcare professionals. Its aim is to stimulate scientific communication in the ever-evolving field of managed care. The American Journal of Managed Care addresses a broad range of issues relevant to clinical decision making in a cost-constrained environment and examines the impact of clinical, management, and policy interventions and programs on healthcare and economic outcomes.